Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,287 | 152,357 | 134,125 | 152,866 | 143,736 |
| Marketable Securities | 657,036 | 687,252 | 554,290 | 596,742 | 606,350 |
| Other current assets | 10,533 | 6,795 | 5,732 | 7,304 | 3,315 |
| TOTAL | $809,204 | $865,129 | $704,270 | $770,100 | $770,103 |
| Non-Current Assets | |||||
| PPE Net | 5,911 | 7,210 | 8,350 | 9,875 | 10,901 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 53,881 | 55,476 | 57,630 | 59,166 | 60,676 |
| TOTAL | $62,092 | $64,986 | $68,280 | $71,341 | $73,877 |
| Total Assets | $871,296 | $930,115 | $772,550 | $841,441 | $843,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,097 | 6,867 | 11,167 | 7,973 | 9,211 |
| Accrued Expenses | 21,236 | 33,216 | 27,773 | 22,362 | 14,890 |
| Other current liabilities | 1,990 | 1,356 | 768 | 1,662 | 1,204 |
| TOTAL | $50,729 | $46,968 | $45,043 | $37,144 | $30,269 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,679 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 42,775 | 44,286 | 45,763 | 58,533 | 61,708 |
| TOTAL | $42,775 | $44,286 | $45,763 | $58,533 | $61,708 |
| Total Liabilities | $93,504 | $91,254 | $90,806 | $95,677 | $91,977 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,522 | 167,383 | 133,890 | 132,742 | 131,179 |
| Common Shares | 168 | 167 | 133 | 132 | 127 |
| Retained earnings | -1,738,290 | -1,662,286 | -1,574,181 | -1,481,969 | -1,400,582 |
| Other shareholders' equity | -991 | 2,509 | -1,340 | -1,158 | -196 |
| TOTAL | $777,792 | $838,861 | $681,744 | $745,764 | $752,003 |
| Total Liabilities And Equity | $871,296 | $930,115 | $772,550 | $841,441 | $843,980 |